Effects of single and repeated daily injections of morphine, clonidine, and l-nantradol on avoidance responding of rats

Ginsenoside Rg1 restores the impairment of learning induced by chronic morphine administration in rats

Rg1, as a ginsenoside extracted from Panax ginseng, could ameliorate spatial learning impairment. Previous studies have demonstrated that Rg1 might be a useful agent for the prevention and treatment of the adverse effects of morphine. The aim of this study was to investigate the effect of Rg1 on learning impairment by chronic morphine administration and the mechanism responsible for this effect. Male rats were subcutaneously injected with morphine (10 mg/kg) twice a day at 12 hour intervals for 10 days, and Rg1 (30 mg/kg) was intraperitoneally injected 2 hours after the second injection of morphine once a day for 10 days. Spatial learning capacity was assessed in the Morris water maze. The results showed that rats treated with Morphine/Rg1 decreased escape latency and increased the time spent in platform quadrant and entering frequency. By implantation of electrodes and electrophysiological recording in vivo, the results showed that Rg1 restored the long-term potentiation (LTP) impaired by morphine in both freely moving and anaesthetised rats. The electrophysiological recording in vitro showed that Rg1 restored the LTP in slices from the rats treated with morphine, but not changed LTP in the slices from normal saline- or morphine/Rg1-treated rats; this restoration could be inhibited by N-methyl-D-aspartate (NMDA) receptor antagonist MK801. We conclude that Rg1 may significantly improve the spatial learning capacity impaired by chonic morphine administration and restore the morphine-inhibited LTP. This effect is NMDA receptor dependent.

Acute and chronic intracerebroventricular morphine infusions affect long-term potentiation differently in the lateral perforant path

Experiments were performed to investigate the effects of acute and chronic intracerebroventricular (icv) morphine infusions via osmotic minipumps on long-term potentiation (LTP) in the lateral perforant path (LPP)-granule cell synapse of the rat dentate gyrus. Although significant antinociceptive activity was observed when morphine was infused (25 nmol/microl/h) for 30 min or 1 h, the activity was not observed in rats receiving morphine chronically for 72 h, and the tail-flick latency of this group was comparable to that of rats receiving saline. LTP induction was significantly attenuated after acute morphine infusion (1 h) in LPP-granule cell synapses of the dentate gyrus. In contrast, LTP induction was augmented after chronic morphine infusion for 72 h. Bath-perfused morphine augmented the baseline population spike (PS) amplitude in rats treated with saline, whereas it attenuated the LTP induced by chronic morphine infusion. Returning the LTP to the level of saline infusion after in vitro morphine perfusion suggests that enhancement of the LTP is a withdrawal-like phenomenon. These results suggest a difference between the effects of acute and chronic intracerebroventricular morphine infusions on synaptic plasticity in the LPP-granule cell synapses of the dentate gyrus.

Morphine augments excitatory synaptic transmission in the dentate gyrus through GABAergic disinhibition

The present study investigated the effect of morphine on synaptic transmission and long-term potentiation (LTP) in the dentate gyrus using rat hippocampal slice preparations. Field excitatory postsynaptic potential (fEPSP) and population spike (PS), evoked by stimulation of the perforant path, were recorded from the dentate molecular layer and the stratum granulosum, respectively. Following application of 10 microM morphine, PS amplitude increased gradually in 10 min and was eventually potentiated by approximately 50%. The phenomenon showed a concentration-dependent manner and was completely canceled by naloxone, a mu opioid receptor antagonist. Furthermore, morphine-induced PS augmentation was not detected in disinhibited hippocampal slices, which suggests that the inhibitory input to the dentate granule cells was required for the facilitatory effect of morphine. Neither fEPSP nor tetanus-induced LTP of PS was altered by morphine application. The data support the hypothesis that mu opioid receptor activity modulates inhibitory recurrent circuits in the dentate gyrus and thereby, indirectly plays a regulatory role for hippocampal excitatory neurotransmission.

Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice

The effects of morphine (6.3, 12.6, and 25.2 mg/kg) on active avoidance behavior of BALB/C mice are explored in three acquisition sessions and in two subsequent performance sessions. Morphine-treated animals showed an increase in avoidance acquisition with respect to control group without differences in performance. However, a dramatical, concomitant rise in the locomotor activity of the animals (increase in the number of crossings during the intertrial intervals) prompted us to transform the data employing a formula with which a measure of actual learning was obtained. Applying this formula, we have observed that morphine administration impairs, dose-dependently, acquisition and performance of avoidance. Thus, the impairing effects of morphine on avoidance could be masked by their stimulant effects on locomotor activity.

Situational specificity of tolerance to decreased operant responding by morphine and l-nantradol

In one experiment, key pressing of rats was maintained under a fixed-ratio schedule of food presentation in a first daily session in one environmental situation, and interruption of a photobeam was maintained under a continuous shock avoidance schedule in a second daily session in another environmental situation. After receiving acute injections of the cannabinoid l-nantradol (0.01-0.3 mg/kg), rats received daily administration of a rate-decreasing dose of the drug after the second session, then before the second session, and then before the first session. Tolerance that developed to decreased avoidance responding in the second daily session did not extend to decreased fixed-ratio responding in the first daily session, but was specific to circumstances coinciding with the pharmacological actions of l-nantradol. In a second experiment lever pressing of squirrel monkeys was maintained under an identical fixed-interval schedule of food delivery in two separate daily sessions in different experimental situations. After receiving once-weekly acute injections of morphine (0.3-3.0 mg/kg), monkeys received daily administration of a rate-decreasing dose of morphine in a counter-balanced order before each session. Just as for experiment 1, tolerance that developed in the environment coinciding with the pharmacological actions of morphine did not immediately generalize to operants in the other environmental situation. Instead, tolerance depended on both pharmacologic action as well as concurrently operating behavioral processes.

Effects of shock intensity on observed tolerance to decreased avoidance responding by clonidine

Interruption of a photobeam by rats was maintained under a Sidman avoidance schedule, and moderate response rates were maintained at low frequencies of electrical stimulation. After acute injections of clonidine, responding decreased, and frequency of electric stimulation increased, in a dose-dependent manner. At a lower intensity of electric stimulation, response-suppressive effects of clonidine did not diminish for up to 40 sessions with daily administration of clonidine. At a higher stimulus intensity, however, response-suppressive effects of clonidine diminished within 15 sessions, and stimulus frequency was at control level after 40 sessions with daily administration of clonidine. Behavioral consequences altered the effects of chronic clonidine so that tolerance was observed at a higher, but not a lower, intensity of electric stimulation.

Effects of fixed-ratio requirement on observed tolerance to decreased responding by clonidine

Responding of rats was maintained under either a 10- or a 40-response fixed-ratio schedule, and "local" rates of responding were 0.29-0.37 responses per sec for both schedules. Clonidine decreased responding for both schedules in a similar and dose-dependent manner, and the largest dose tested (0.3 mg/kg) completely suppressed behavior. When 0.1 mg/kg was administered immediately prior to 30 daily experimental sessions, FR10 responding recovered to control levels within 15 sessions, whereas FR40 responding recovered only to approximately 60% of control level at asymptote. These results continue to identify boundary conditions for the influence of reinforcer loss on tolerance development, and they emphasize the overriding influence of behavioral processes on observed tolerance to the behavioral effects of drugs.

Associative influences on tolerance to decreased fixed-interval responding by clonidine

Responding of rats was maintained under a 5-min fixed-interval schedule of food presentation. One group of animals (n = 5) received the alpha-2-agonist clonidine (0.1 mg/kg/day) before experimental sessions for 16 weeks. Additional animals (n = 5) also received 0.1 mg/kg/day for 16 weeks but experienced drug administration after sessions for 4 weeks, before sessions for 4 weeks, after sessions for 4 weeks, and then finally, before sessions for 4 weeks. Animals receiving clonidine before daily experimental sessions for the entire period developed tolerance to decreased responding within 3 weeks, and their responding remained near control levels except when clonidine was occasionally preceded by the alpha-2-antagonist yohimbine. Animals receiving clonidine after sessions did not develop tolerance, and responding was markedly suppressed during the first exposure to presession clonidine. When these animals subsequently received clonidine again after sessions, responding was disrupted (increased) in spite of continued drug administration as if animals were "dependent" on clonidine in specific circumstances. When these animals again received clonidine before sessions, responding was partially suppressed in spite of uninterrupted drug administration as if animals had "lost" tolerance in specific circumstances. Tolerance to the behavioral effects of clonidine on fixed-interval responding was not determined by the presence of drug alone, but by the associative influence of drug-related effects in the presence of specific environmental stimuli.

Situational specificity of tolerance to decreased operant responding by cocaine

Responding of rats was maintained in three different environmental situations each day. Interruption of a photobeam was maintained under a shock avoidance schedule in the first session, lever pressing was maintained under a 5-min fixed-interval (FI) schedule of food presentation in a second session, and nose-key pressing was maintained under a 30-response fixed-ratio (FR) schedule of food presentation in a third session. After receiving once-weekly injections of cocaine (3-17 mg/kg) prior to each of the sessions, animals received daily administration of 13 mg/kg after responding in the third daily session for four weeks, before responding in the third session for four weeks, before responding in the second daily session for four weeks, and then before responding in the first daily session for four weeks. Tolerance that developed in the environment that was coincident with the pharmacological actions of cocaine did not extend to operants in other environmental situations. Instead, tolerance to the behavioral effects of cocaine was specific to particular stimulus conditions associated with drug administration, indicating that the expression of tolerance depended on both pharmacologic action as well as concurrently operating behavioral processes.

Tolerance to behavioral effects of clonidine after chronic administration of morphine

Male rats (Buffalo strain) were studied under a procedure in which each 30th lick of a drinking tube resulted in the delivery of 0.01 ml water. The effects of clonidine HC1 (0.003-0.3 mg/kg, IP) were determined before, during and after exposure to conditions in which a morphine sulfate solution (0.5 mg/ml in 0.4% saccharin) was the only source of fluid. After either 10 or 80 days exposure to the chronic morphine regimen, rats were maintained under a repetitive cycle in which the morphine was available for 3 days and then removed for 4 days. The subjects consumed an average of 100 mg/kg/day morphine during the times it was available. The effects of clonidine were redetermined once weekly, on the 4th day after removal of the morphine solution. The effects of clonidine were also determined after morphine was removed for more prolonged periods (18-67 days). Chronic exposure to the morphine solution resulted in a 4- to 5-fold shift to the right in the dose-effect curve for clonidine (decreased responding). ED50 values returned to pre-morphine levels when rats were tested at longer post-morphine times (e.g., 18 days). Under the conditions of this experiment, chronic exposure to morphine produced marked cross-tolerance to the behavioral effects of clonidine.